107 related articles for article (PubMed ID: 21905584)
1. Myeloproliferative neoplasms: an overview.
Finnegan K
Clin Lab Sci; 2011; 24(3):178-82. PubMed ID: 21905584
[No Abstract] [Full Text] [Related]
2. Myeloproliferative neoplasms: the role of molecular markers.
Collins L
Clin Lab Sci; 2011; 24(3):183-6. PubMed ID: 21905585
[No Abstract] [Full Text] [Related]
3. [Review of changes introduced by the new WHO classification (4th edition) of myeloid neoplasms. An overview].
Komatsu N
Rinsho Ketsueki; 2009 Mar; 50(3):127-33. PubMed ID: 19352078
[No Abstract] [Full Text] [Related]
4. WHO classification of myeloid neoplasms and leukemia.
Wandt H; Haferlach T; Thiede C; Ehninger G
Blood; 2010 Jan; 115(3):748-9; author reply 749-50. PubMed ID: 20093414
[No Abstract] [Full Text] [Related]
5. [Myeloproliferative neoplasms and related diseases].
Kirito K
Rinsho Ketsueki; 2009 Mar; 50(3):134-46. PubMed ID: 19352079
[No Abstract] [Full Text] [Related]
6. World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants.
Vardiman J; Hyjek E
Hematology Am Soc Hematol Educ Program; 2011; 2011():250-6. PubMed ID: 22160042
[TBL] [Abstract][Full Text] [Related]
7. Introduction to a review series on myeloproliferative neoplasms.
Cazzola M
Blood; 2017 Feb; 129(6):659. PubMed ID: 28028028
[No Abstract] [Full Text] [Related]
8. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
Anastasi J
Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
[TBL] [Abstract][Full Text] [Related]
9. A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene.
Saba N; Safah H
Blood; 2013 Aug; 122(6):861. PubMed ID: 24079014
[No Abstract] [Full Text] [Related]
10. [Molecular biology and new drug therapy for myeloproliferative neoplasm].
Kitanaka A; Shide K; Shimoda K
Rinsho Ketsueki; 2013 Oct; 54(10):1697-703. PubMed ID: 24064819
[No Abstract] [Full Text] [Related]
11. [Clinical aspects of myeloproliferative disorders excluding CML].
Komatsu N
Rinsho Ketsueki; 2008 Oct; 49(10):1411-9. PubMed ID: 18833926
[No Abstract] [Full Text] [Related]
12. Unusual infant eosinophilia: myeloid neoplasm with FGFR1 abnormality.
Li W; Cooley LD
Blood; 2016 Sep; 128(10):1440. PubMed ID: 27769039
[No Abstract] [Full Text] [Related]
13. [A revised 4 edition WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2017: myeloid neoplasms].
Kovrigina AM
Arkh Patol; 2018; 80(6):43-49. PubMed ID: 30585592
[TBL] [Abstract][Full Text] [Related]
14. [Myeloproliferative neoplasms].
Komatsu N
Rinsho Ketsueki; 2013 Jan; 54(1):71-8. PubMed ID: 23391649
[No Abstract] [Full Text] [Related]
15. Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.
Iurlo A; Gianelli U; Cattaneo D; Thiele J; Orazi A
Am J Hematol; 2017 Apr; 92(4):E48-E51. PubMed ID: 28109016
[No Abstract] [Full Text] [Related]
16. [Current diagnosis of myeloproliferative neoplasms (2008 WHO classification)].
Frenkel' MA
Klin Lab Diagn; 2011 Jan; (1):43-9. PubMed ID: 21433318
[TBL] [Abstract][Full Text] [Related]
17. Classification of Philadelphia translocation-negative myeloproliferative neoplasms: its impact on data from clinical trials.
Naresh KN
J Clin Oncol; 2009 Nov; 27(31):e175-6; author reply e177-8. PubMed ID: 19704052
[No Abstract] [Full Text] [Related]
18. JAK1 somatic mutation in a myeloproliferative neoplasm.
Arulogun SO; Choong HL; Taylor D; Ambrosoli P; Magor G; Irving IM; Keng TB; Perkins AC
Haematologica; 2017 Aug; 102(8):e324-e327. PubMed ID: 28550193
[No Abstract] [Full Text] [Related]
19. Defining targets in myeloproliferative disorders: reflecting on what is important.
Griesshammer M
Hematol Oncol; 2009 Jun; 27 Suppl 1():2-4. PubMed ID: 19468984
[TBL] [Abstract][Full Text] [Related]
20. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
Vardiman JW
Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
